Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

Chief Financial Officer

Interim CEO and CSO

Chief Scientific Officer

Chief Operating Officer

President

CEO and Executive Co-Chairman

CEO and Executive Chairman

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates through two segments, Biopharmaceuticals and Bioprocessing. Its lead anti-fibrotic candidate is IBIO-100 for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-202, which is the Nucleocapsid (N) protein for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties; and offers a range of process development, manufacturing, and bio analytic services. iBio, Inc. has a license agreement with University of Pittsburgh; a non-exclusive agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with RubrYc, as well as a research collaboration with the National Institute of Allergy and Infectious Diseases to investigate the potential of the company's AI-driven epitope steering platform for the development of a vaccine for Lassa fever. The company was incorporated in 2008 and is headquartered in Bryan, Texas.

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers i...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-01	Premium	sold	Premium	Premium	Premium	See Remarks
2023-10-03	Premium	sold	Premium	Premium	Premium	See Remarks
2023-10-02	Premium	sold	Premium	Premium	Premium	See Remarks
2023-08-28	Premium	sold	Premium	Premium	Premium	See Remarks
2023-07-27	Premium	sold	Premium	Premium	Premium	See Remarks
2023-07-12	Premium	sold	Premium	Premium	Premium	See Remarks
2023-06-26	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-06-22	Premium	back to issuer	Premium	Premium	Premium	See Remarks
2023-06-21	Premium	sold	Premium	Premium	Premium	See Remarks
2023-05-22	Premium	sold	Premium	Premium	Premium	See Remarks
2023-04-24	Premium	sold	Premium	Premium	Premium	See Remarks
2023-03-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-03-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-03-23	Premium	sold	Premium	Premium	Premium	See Remarks
2023-02-21	Premium	sold	Premium	Premium	Premium	See Remarks
2023-01-20	Premium	acquired	Premium	Premium	Premium	Interim CEO and CSO
2022-11-11	Premium	acquired	Premium	Premium	Premium	See Remarks
2022-11-11	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-03-10	Premium	sold	Premium	Premium	Premium	See Remarks
2021-03-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2020-12-01	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2020-08-11	Premium	sold	Premium	Premium	Premium	-
2020-08-10	Premium	sold	Premium	Premium	Premium	-
2020-08-07	Premium	acquired	Premium	Premium	Premium	-
2020-08-07	Premium	sold	Premium	Premium	Premium	-

IBIO - iBio Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for IBIO